Patent Assignment
Reel/Frame 067860/0930
Assignment of Assignor's Interest
Recorded: 2024-06-27
Pages: 3
Assignor
ABBVIE BIOTECHNOLOGY LTD
Executed: 2024-02-27
Assignee
GENMAB A/S
CARL JACOBSENS VEJ 30, VALBY, DK-2500, DENMARK
Covered Property
(1)
Bispecific Antibody Against CD3 and CD20 in Combination Therapy for Treating Diffuse Large B-Cell Lymphoma
Application:
18/160,391 →
Publication:
US 2023/0303693
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 27, 2024
From: CHIU, CHRISTOPHER W.L.
To: GENMAB A/S
Reel/Frame 067860/0601 →
Assignment of Assignor's Interest
Jun 27, 2024
From: DINH, MINH H.; STIRNER, MARIANA COTA; SZAFER-GLUSMAN, ILIANA EDITH
To: ABBVIE BIOTECHNOLOGY LTD
Reel/Frame 067860/0834 →
Security Interest
Dec 15, 2025
From: GENMAB A/S; GENMAB B.V.; GENMAB HOLDING B.V.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 073933/0597 →
Notice of Grant of Security Interest in Patents
Dec 15, 2025
From: GENMAB A/S; GENMAB B.V.; GENMAB HOLDING B.V.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 073949/0722 →